Cerebral ischaemia is implicated in poor outcome after brain injury, and is a very common postmortem finding. The inability of the brain to store metabolic substrates, in the face of high oxygen and glucose requirements, makes it very susceptible to ischaemic damage. The clinical challenge, however, remains the reliable antemortem detection and treatment of ischaemic episodes in the intensive care unit. Outcomes have improved in the traumatic brain injury setting after the introduction of progressive protocol-driven therapy, based, primarily, on the monitoring and control of intracranial pressure, and the maintenance of an adequate cerebral perfusion pressure through manipulation of the mean arterial pressure. With the increasing use of multi-modal monitoring, the complex pathophysiology of the injured brain is slowly being unravelled, emphasizing the heterogeneity of the condition, and the requirement for individualization of therapy to prevent secondary adverse hypoxic cerebral events. Brain tissue oxygen partial pressure (Pb O 2 ) monitoring is emerging as a clinically useful modality, and this review examines its role in the management of brain injury.
Neuronal excitotoxicity, oxidative stress, mitochondrial dysfunction, lipid peroxidation with loss of membrane integrity and disturbances in ion homeostasis, free radical production, subsequent inflammation, necrosis and even apoptosis all play a role in the cascade of post-ischaemic events. 3 101 With targeted therapy having shown promising reductions in mortality, 70 21 11 brain tissue oxygen monitoring may provide a further tool not only to elucidate the pathophysiology, but also individualise therapeutic targets. 65 
Cerebral oxygenation and cerebral perfusion pressure targets
Cerebral blood flow (CBF) is regulated by metabolic requirements under normal conditions, so-called flowmetabolism coupling, and ensures adequate cerebral oxygenation. Temporal patterns of CBF disturbances after traumatic brain injury (TBI) have been well documented, 2 58 with optimal therapy on the first post-injury day, not necessarily the most appropriate on subsequent days. High intracranial pressures (ICPs) and cerebral hypoxia show strong correlations with poor outcome, 47 making the control of these parameters with a sufficient cerebral perfusion pressure (CPP) critically important (see the review by Steiner and Andrews in this postgraduate issue). The exact level of CPP required following TBI has been subject to much debate, 68 76 86 the latest definitive guidance being the downward revision of the Brain Trauma Foundation's guidelines on CPP targets (available from http://www2.braintrauma. org/guidelines) in 2003, suggesting a CPP target of 60, rather than 70 mm Hg. The proviso is, however, that in selected patients, where there is evidence of regional or global ischaemia, the CPP target may need to be higher. Individualized CPP optimization, therefore, becomes dependent on, amongst other things, the monitored levels of brain oxygenation.
Existing monitors of cerebral oxygenation

Imaging
Positron emission tomography (PET) Metabolic imaging of the brain after the fact that the most unstable patients may not get scanned (selection bias), PET is still regarded as the 'gold standard' for visualizing cerebral oxygen use. Early post-injury PET has identified the presence of regional ischaemia, 13 14 with quantification of the ischaemic brain volume.
Magnetic resonance spectroscopy (MRS)
MRS is an application of magnetic resonance imaging (MRI) whereby spectra of metabolic changes in living tissue are obtained. The outcome predictive value of noninvasively measuring brain metabolites (biomarkers of injury processes) using MRS, is increasingly being demonstrated. 22 83 Measurement of adenosine triphosphate (ATP) using phosphorous spectroscopy ( 31 P-MRS) 69 and lactate using proton spectroscopy ( 1 H-MRS) 82 after brain injury can provide evidence of cerebral ischaemia, while N-acetyl aspartate represents neuronal integrity. The post-processing and availability of MRS preclude its routine clinical use at present.
Bedside Jugular venous oximetry (S j O 2 )
Catheterization of the internal jugular vein to measure the oxygen saturation of the effluent cerebral blood at the jugular bulb, allows assessment of the global oxygenation status of the brain, providing some insight into the adequacy of CBF, especially during manoeuvres such as hyperventilation. A significant association between jugular venous desaturation and poor neurological outcome exists, 24 with poor outcome in 55% of patients with no episodes of desaturation, 74% with one episode and 90% with multiple episodes. A shortcoming, however, is the inability of Sj O 2 to detect regional ischaemia, with PET evidence 13 of approximately 13% of the brain being ischaemic before Sj O 2 levels decrease below 50%.
Near-infrared spectroscopy (NIRS)
Penetration of human tissue by light in the near-infrared band and its resultant absorption and scatter allows assessment of cerebral changes in oxyhaemoglobin (HbO 2 ), deoxyhaemoglobin (Hb) and cytochrome oxidase. An attractive non-invasive regional monitor of cerebral oxygenation, NIRS has been beset by issues of extra-cranial blood contamination, light shielding, optimal optode placement, sample volume inaccuracies and the robustness of the derived algorithms. Spatial resolution and equipment improvements are addressing these issues, but to date NIRS has yet to find a clear role in routine clinical practice. 4 Intracerebral microdialysis Microdialysis (the subject of a separate review by Smith and Tisdall in this postgraduate issue) has become a feasible clinical bedside technique in the intensive care unit (ICU), 33 72 with metabolic patterns 34 79 supplying valuable information on the adequacy of cerebral oxygenation.
Brain tissue oxygen tension (P bO 2 ) Improvements in technology, and the pitfalls of the techniques described above, have led to the introduction of brain tissue oxygenation monitoring.
What is brain tissue oxygen partial pressure?
Pb O 2 is the partial pressure of oxygen in the extra-cellular fluid of the brain and reflects the availability of oxygen for oxidative energy (ATP) production. It represents the balance between oxygen delivery and consumption, and is influenced by changes in capillary perfusion. Distance from the supplying capillaries and possible barriers to oxygen diffusion 66 may be particularly important after injury. An experimental global ischaemia model 81 examining the relationships between Pb O 2 , local CBF and NIRS-derived CMRO 2 and AVDO 2 (arterio-venous difference in oxygen content) has also suggested that the relative predominance of arterial or venous vessels in the immediate proximity of the Pb O 2 sensor may determine whether coupling exists between Pb O 2 and CBF 15 19 46 or between Pb O 2 and OEF (AVDO 2 ), respectively.
The equipment
The two most commonly used systems to date are the Licox (GMS, Kiel-Mielkendorf, Germany) and the Neurotrend (Codman, Johnson & Johnson, Raynham, MA, USA). With good temporal resolution of acute biological changes, accomplished by the rapid response rates 35 of the Pb O 2 systems, timely therapeutic interventions and assessment of the subsequent responses is possible. 
Measurement principles
The Licox system provides PO 2 measurement, with or without brain temperature (thermocouple), in an estimated 7.1-15 mm 2 PO 2 -sensitive area. The PO 2 probe utilizes a closed polarographic (Clark-type) cell with reversible electrochemical electrodes (Fig. 1) . Oxygen, which has diffused from the brain tissue across a semi-permeable membrane, is reduced by a gold polarographic cathode producing a flow of electrical current directly proportional to the oxygen concentration. This oxygen-consuming process is temperature-dependent.
In addition to Pb O 2 , Neurotrend also offers Pb CO 2 , pH and temperature. Its predecessor, the Paratrend 7, was an intra-arterial monitor which was adapted for intracerebral use. 8 Although Neurotrend has been used both for research and clinical purposes, its manufacture has now been discontinued. The Neurotrend (Fig. 2 ) comprises three optical sensors (PO 2 , PCO 2 and pH) and a thermocouple contained within the distal 25 mm of a 0.5 mm diameter microporous polyethylene tube. PO 2 measurement occurs by quenching (reduction) of the intensity of a fluorescent optical emission from an indicator (ruthenium) in the presence of oxygen (following light pulses from a blue light emitting diode). In contrast to the Licox, this process does not consume oxygen and does not affect the measured oxygen level. The pH sensor relies on optical absorption, the local pH affecting the intensity of light transmitted through an indicator (phenol red). The PCO 2 sensor, similarly, is a CO 2 -selective pH sensor.
Calibration and insertion
Using a sensor-specific pre-calibrated smart card, the Licox sensor can be inserted without delay, while the less userfriendly Neurotrend sensor requires a 31 min calibration in a chamber using three calibration gases before insertion.
Sensors can be inserted, either via a cranial access device sited through a craniotomy, on the ICU, or under direct vision at surgery. Purpose-designed triple lumen cranial access devices 44 allow simultaneous ICP, intracerebral microdialysis and Pb O 2 monitoring. Ideally, this should occur in an anatomically similar area of white matter where Pb O 2 readings are likely to be more stable. Postinsertion CT confirmation of probe position in the brain parenchyma (Fig. 3) is important for interpretation of readings. Transiently increasing the FI O 2 and observing the corresponding Pb O 2 increase, is advised to exclude the presence of surrounding micro-haemorrhages or sensor damage at insertion. A 'run-in' or equilibration time of up to a half hour is required before readings are stable. Adjustment of insertion depth (when used through an access device) is allowed by the Neurotrend, but not the Licox.
Comparison
Comparative studies have been carried out to evaluate their functioning and reliability under experimental 35 and clinical conditions. 45 In test conditions, the Licox was slightly more accurate, with the Neurotrend under-reading at low Pb O 2 . Both sensors displayed slight drift towards lower oxygen concentrations over time, but this was not thought to prohibit long-term use. The Neurotrend measured Pb CO 2 and pH very accurately. Clinically, the Neurotrend sensor underread Pb O 2 (in contrast to the reported overestimation 96 of the Paratrend 7), and was less robust than the Licox sensor. (1), the three optical sensors, namely the Pb O2 sensor (2) (ruthenium dye in a silicone matrix), the Pb CO2 sensor (3) (phenol red in a bicarbonate solution), the pH sensor (4) (phenol red in a polyacrylamide gel) and the thermocouple (5) (copper and constantan wires) all suspended in phenol red and polyacrylamide gel (6) and implanted in the brain parenchyma (7) . (Adapted from the manufacturer's manual.) Tissue oxygen monitoring in acute brain injury
Validation with existing techniques
Establishing the relevance of a monitor requires validation of the measured variables and their relationships with the existing clinical and experimental techniques (Table 1) .
Clinical utility
Normal values
Normal brain gas tension measurements have been acquired experimentally, but human measurements have been restricted to 'normal' values during neurosurgery and in 'normal-appearing' brain after TBI. A feline study 100 revealed a normal Pb O 2 of 42 (9) 
Hypoxic thresholds
The identification of hypoxic tissue allows the institution of early potentially corrective interventions, and also provides meaningful therapeutic end-points. These values need to be considered in the context of probe type, probe site, underlying pathology and duration of hypoxia before irreversible damage occurs. Various Pb O 2 hypoxic thresholds (Table 2) have been proposed.
Safety
Initial concerns regarding the invasiveness of these intraparenchymal sensors and the risk of haemorrhage and infection, have proved unfounded. Eleven studies 6 9 17 62 79 91 96-98 102 103 including 552 patients reported no infections and three iatrogenic haematomas with only one requiring surgical evacuation. Measurement accuracy with negligible zero drift was also a consistent finding. 6 17 97 98 Drawbacks Some of the reported problems include insertion trauma with subsequent gliosis and the ability to adequately position and secure sensors in position. The focal nature of these monitors must also be emphasized.
Global assumptions of a focal monitor
Jugular venous oxygen saturation (Sj O 2 ) monitoring provides global cerebral oxygenation determination and can be used to calculate the arterio-venous oxygen content difference. Pb O 2 sensors are extremely localized, only sampling approximately 15 mm 2 of tissue around the tip. The positioning of the sensor, however, becomes a vital question in the interpretation of the readings. In 'tissue at risk' regions near focal pathology, global assumptions cannot be made and the monitor is purely focal, but when positioned in areas of seemingly normal tissue, or in areas of diffuse injury, the Pb O 2 can be regarded as an 
Dynamic indices
In addition to static baseline Pb O 2 readings, oxygen regulatory mechanisms challenged dynamically, may provide insight into the underlying pathophysiology and outcome prediction.
Pb O 2 reactivity
The increase in Pb O 2 relative to an increase in arterial PO 2 is termed brain tissue oxygen reactivity. It is believed that this reactivity is controlled by an oxygen regulatory mechanism (cf. CBF autoregulation), and that this mechanism may be disturbed after brain injury. van Santbrink and colleagues 99 examined the 'brain tissue oxygen response' (the degree of change in Pb O 2 in response to changes in Pa O 2 ) and showed that greater responsiveness in the first 24 h post-injury was associated with an unfavourable outcome (P=0.02); with multiple logistic regression analysis supporting its value as an independent predictor of unfavourable outcome (odds ratio 4.8). The effect of Pa CO 2 on this mechanism was illustrated experimentally by Hoffman 43 Correctly positioned Pb O 2 monitoring allows not only assessment of the effect and reversibility of temporary aneurysm clipping, but can also be indicative of the correct positioning of the subsequent permanent clip. 23 Hypoxic Pb O 2 levels confirmed compromised perfusion detected on preoperative single photon emission computed tomography (SPECT) and cerebral angiography. 36 In a study of 46 patients undergoing craniotomy for aneurysm clipping, 51 
AVM surgery
Pb O 2 measurement has been used to investigate the oxygenation of cerebral tissue supplied by vessels with AVMs. 38 In total, 13 patients undergoing resection of AVMs were compared with 8 non-ischaemic patients undergoing aneurysmal surgery (the controls). Low Pb O 2 , but normal Pb CO 2 and pH (in contrast with raised Pb CO 2 and acidosis seen in acute occlusive disease with ischaemia 39 ) before AVM resection suggested low perfusion and chronic hypoxia with possible metabolic adaptation and subsequent hypometabolism, while the marked Pb O 2 increases post-resection indicate hyperperfusion with its attendant problems. Apart from enhancing the understanding of AVM pathophysiology, this study reaffirms the feasibility of intraoperative Pb O 2 monitoring.
Tumours
The extent and nature of the effects of oedema on brain tissue oxygen surrounding tumours was investigated perioperatively in 19 patients. 71 MRI-based stereotaxis was used to guide sensor placement into the peritumoral area before craniotomy and the effects of dural opening and resection on the Pb O 2 was noted. In patients with swelling, Pb O 2 increased significantly on dural opening (P<0.05), and postresection (P<0.05), implying the presence of ischaemic processes with oedema. This emphasizes the importance of maintaining adequate CPP in patients undergoing brain tumour surgery. Pb O 2 monitoring during awake craniotomy for tumour resection has also been reported. 93 
Anaesthetic drug pharmacodynamics
Studies investigating the dose effects of anaesthetic agents such as isoflurane, 41 desflurane 37 and propofol 48 on cerebral autoregulation and oxygenation to levels of EEG burstsuppression have also utilized Pb O 2 monitoring. The inhalational agents demonstrate a dose-related loss of autoregulation with corresponding increase in Pb O 2 as long as the CPP is maintained, while propofol displays no such changes and flow-metabolism coupling remains intact.
Therapeutic and research interventions
The clinical utility and temporal responsiveness of Pb O 2 to fraction of inspired oxygen (FI O 2 ) increases, Pa CO 2 changes (hyper-and hypoventilation) and haemorrhage to 70% blood loss or cardiac arrest with immediate subsequent resuscitation, were experimentally validated by Manley and colleagues. 57 In addition, investigation of pathophysiological mechanisms after brain injury in studies combining Pb O 2 monitoring with PET, have proposed the presence of microcirculatory abnormalities with significant gradients for oxygen diffusion in injured tissue. 66 Structural evidence for these pathophysiological changes has also been well documented. 77 As more data are accumulated regarding hypoxic thresholds, and the clinical and outcome significance of Pb O 2 in various clinical situations is established, the changes in baseline Pb O 2 levels in response to potential therapeutic or research interventions gives weight to their clinical value. Interventions include the following.
Elevation of CPP
A comparative study using dopamine or norepinephrine to elevate CPP from 65 to 85 mm Hg, showed no significant increase in the Pb O 2 values monitored in predominantly normal-appearing brain. 49 However, targeted Pb O 2 sensors in CT hypodense lesions in nine patients 89 (with hypoperfusion confirmed with SPECT) revealed significant improvements in Pb O 2 readings with induced hypertension (r 2 =0.74). Significantly higher Pb O 2 has been shown at a CPP >70 mm Hg than <70 mm Hg in TBI patients (P<0.001) 9 (cf. Fig. 4 ).
Hyperventilation
An experimental study in 12 healthy pigs 10 comparing Pb O 2 (Licox), rCBF (thermal diffusion system) and metabolic microdialysis markers at baseline, during moderate (Pa O 2 =30 mm Hg) and profound (Pa O 2 =20 mm Hg) hyperventilation revealed that both moderate and profound Tissue oxygen monitoring in acute brain injury hyperventilation may cause insufficient regional oxygen supply and anaerobic metabolism. The value of Pb O 2 as a monitor of excessive hyperventilation (cf. Sj O 2 ) was illustrated in a head injury study of 90 patients 6 where the Pa CO 2 was decreased with hyperventilation and Pb O 2 decreased significantly (P<0.001). Importantly, the risk of secondary cerebral ischaemia with hyperventilation increased over time.
Hypothermia
Despite the negative findings of the National Acute Brain Injury Study: Hypothermia 12 (no improvement in outcome using hypothermia to 33 C within 8 h of TBI) and the Intraoperative Hypothermia for Aneurysm Surgery Trial 94 (no improvement in neurological outcome using intraoperative hypothermia in good grade SAH), hypothermia is thought to reduce secondary brain injury following TBI by metabolic suppression and reduction of inflammation, free radicals, cytokines and excitatory amino acids. Pb O 2 and direct brain temperature were measured in 58 patients after severe TBI, 85 and revealed decreases in the Pb O 2 with mild hypothermia (34) (35) (36) C) accompanied by decreases in ICP and Pb CO 2 and increases in brain pH. Decreased metabolic requirements and lowering of the Pb O 2 critical threshold were concluded. Another Pb O 2 study in 30 patients 28 indicated that 35 C might be the optimal temperature after severe TBI.
Decompressive craniectomy
In patients with intractable intracranial hypertension, despite maximal medical therapy, surgical (either bi-frontal or unilateral) removal of a part of the skull may be considered. The benefits of this technique and whether it offers any advantage in outcome and quality of outcome over the use of barbiturate coma, although not yet known, is currently the subject of the multi-centre RESCUE-ICP study (Randomized Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of IntraCranial Pressure; available at http://rescueicp.com/). Recent studies have added the use of Pb O 2 monitoring to the traditional ICP/CPP parameters in assessing the impact of this last-resort procedure. A retrospective review 91 of 20 ICP and Pb O 2 monitored SAH patients who ultimately underwent surgical hemicraniectomy for intracranial hypertension, revealed 12 patients in whom Pb O 2 decreases to <10 mm Hg were the first sign of deterioration. Most notably, hypoxic Pb O 2 readings were present 13.4 h (mean) before development of intracranial hypertension in nine patients hinting at an important potential therapeutic window. Another decompressive hemi-craniectomy study 87 revealed favourable decreases in ICP and increases in CPP, but also sustained improvement in cerebral oxygenation. Patients with severe brain hypoxia before surgery were likely to have poorer outcomes, raising the possibility of using Pb O 2 monitoring to select the patients who might benefit most from surgical decompression. Subsequently, a study 75 
Hyperoxia
The therapeutic use of normobaric hyperoxia, to counter the effects of cerebral ischaemia by facilitating oxidative metabolism, has received increasing attention in the management of severe TBI. 1 5 55 Although attractive in its ease of use (by increasing the FI O 2 in ventilated patients), the target population, the dose and the duration of hyperoxia have yet to be defined. While studies utilizing Pb O 2 and microdialysis monitoring agree universally on the elevation of the Pb O 2 with this intervention, and have documented the resultant biochemical effects, 56 67 73 74 95 the clinical benefit of this therapy needs further elucidation.
Other cerebral tissue parameters
This review has focused on oxygen partial pressure in the tissue, but the use of the Neurotrend sensor also allowed Pb CO 2 and pH monitoring. The relationships of these variables to other brain parameters have been well documented in a study by Clausen and colleagues 9 where they demonstrated that Pb CO 2 was significantly higher at 6 h post-injury in patients with poor outcomes compared with patients with good outcomes (P<0.05). They also showed that Pb CO 2 was significantly higher at a CPP below 70 mm Hg as opposed to higher (P<0.0001), and also significantly higher at a Pb O 2 below 10 mm Hg as opposed to higher (P<0.0005). These findings were in the face of a stable Pa CO 2 . Brain pH differences at these CPP and Pb O 2 thresholds were also significant (both P<0.0001). Low brain pH has also been correlated with adverse outcome (P=0.003). 31 These parameters may, therefore, also provide useful end-points in optimization of therapy. Brain temperature measurement (available with both Neurotrend and Licox) has allowed investigation of hyperthermia 78 90 and hypothermia. 28 85 103 Cerebral oxygenation and outcome prediction 
The future
The invasiveness of the Pb O 2 technique will always be an issue and may limit its usefulness in patients with coagulopathy, for instance. Combining parameters such as ICP and Pb O 2 into a single probe may reduce the number of probes inserted, but the ideal remains a non-invasive monitor. Better integration of the collected data with continuous online derived indices at the bedside may also facilitate patient optimization. Routine use of dynamic challenges (e.g. increases in CPP or FI O 2 when cerebral hypoxia presents), may identify individualized therapeutic targets.
Conclusion
Brain tissue oxygen partial pressure measurement contributes to the prevention of delayed cerebral damage after TBI and SAH. The integrated, continuous monitoring of Pb O 2 is now accepted as being safe and feasible. Reliable bedside Pb O 2 monitoring, both at baseline, and during the course of interventions such as CPP manipulation and hyperventilation, complements the use of existing cerebral monitors, and with the increasingly multi-modal approach of cerebral monitoring and data recording, may allow appropriate individualization of therapy. The rapid response of Pb O 2 sensors to altering tissue oxygen levels, together with further Pb O 2 threshold data, will allow more accurate identification of adverse cerebral conditions. Coupled with modalities such as ICP, transcranial Doppler and brain chemistry (microdialysis), more timely intervention and prognostication may be allowed. Pb O 2 measurement, therefore, is emerging as a useful clinical tool and, taken within the context of 
